No Data
No Data
Bluechiip Secures Expansion Order From US Biotech Client
Technology company Bluechiip (ASX:BCT) secured an expansion order for its sample management products from an unnamed biotech firm in California, US, according to a Wednesday filing with the
Bluechiip to Raise Up to AU$4.8 Million From Share Placement, Entitement Offer
Bluechiip (ASX:BCT) is targeting to raise a maximum of AU$4.8 million from an institutional placement and an entitlement offer, a Monday filing said. The company will raise AU$840,000 from the institu
Bluechiip Secures R&D Tax Rebate for Fiscal Year 2023
Bluechiip (ASX:BCT) secured a AU$931,000 rebate for the fiscal year ended June 30 as part of the Australian government's research and development tax incentive scheme, the medical technology firm said
Bluechiip Secures Order From Top Pharmaceutical Firm
Bluechiip (ASX:BCT) secured an order from a "third global top‐20 pharmaceutical company" for its advanced sample‐management solution, the wireless tracking services company said Thursday. The unnamed
Bluechiip Raises AU$1.6 Million for Production Scaling, Sales Expansion; Shares Fall 4%
Bluechiip (ASX:BCT) raised AU$1.6 million for the wireless tracking services company's continued production scaling and sales expansion, especially in the North American market, and for working capita
Bluechiip (ASX:BCT) Secures $2.2m and Announces Share Purchase Plan
No Data